文献速递复苏、休克与脓毒症心脑血管急症

COVID-19疫情期间体外心肺复苏对院外心脏骤停患者的影响

Impact of COVID-19 pandemic on out-of-hospital cardiac arrest patients who received extracorporeal pulmonary resuscitation.
PubMed 文献 · Am J Emerg Med · 2025-08-25
一句话结论基于日本全国JAAM-OHCA登记,疫情期间院外心脏骤停患者接受ECPR的频率下降(OR 0.86),但30天良好神经功能预后无显著差异(OR 0.92)。

该研究利用日本全国JAAM-OHCA登记数据,纳入2019年至2022年接受ECPR的院外心脏骤停患者1903例(疫情前组681例,疫情期间组1222例),比较疫情前(2019年1月1日至2020年3月31日)与疫情期间(2020年4月1日至2022年12月31日)的ECPR频率及结局。结果显示,疫情期间ECPR频率下降(4.4% vs 3.8%,OR 0.86,95%CI 0.78-0.94,p<0.01),中断时间序列分析显示每月减少17.2例(95%CI -26.0至-8.5,p<0.01)。主要终点30天良好神经功能预后(脑功能分类评分1-2分)在两组间无显著差异(12.5% vs 12.6%,OR 0.92,95%CI 0.67-1.30,p=0.64)。结论认为,尽管ECPR频率下降,但包括良好神经功能预后在内的预后未见差异。

要点

  • 疫情期间院外心脏骤停患者接受ECPR的频率下降:疫情前4.4%(681/15344)vs 疫情期间3.8%(1222/32020),OR 0.86(95%CI 0.78-0.94),中断时间序列分析显示每月减少17.2例。
  • 30天良好神经功能预后(脑功能分类评分1-2分)在疫情前组为12.5%(85/681),疫情期间组为12.6%(154/1221),多因素logistic回归OR 0.92(95%CI 0.67-1.30,p=0.64),无显著差异。
  • 中断时间序列分析显示,疫情期间30天良好神经功能预后的比例无差异(相对风险1.16,95%CI 0.70-1.96,p=0.56)。
  • 多因素logistic回归调整了年龄、性别、目击心脏骤停、旁观者心肺复苏、初始/到院时可电击心律及呼叫至体外膜氧合启动时间。

适用人群与场景

  • 日本全国JAAM-OHCA登记中2019年至2022年接受ECPR的院外心脏骤停患者,共1903例(疫情前组681例,疫情期间组1222例)。

研究设计与关键结果

  • 研究类型:基于全国JAAM-OHCA登记的回顾性队列研究,比较疫情前(2019年1月1日至2020年3月31日)与疫情期间(2020年4月1日至2022年12月31日)接受ECPR的院外心脏骤停患者。
  • 样本量:共1903例ECPR病例,疫情前组681例,疫情期间组1222例。
  • 主要终点:30天良好神经功能预后(脑功能分类评分1-2分),疫情前组12.5%(85/681)vs 疫情期间组12.6%(154/1221),OR 0.92(95%CI 0.67-1.30,p=0.64),无显著差异。
  • ECPR频率:疫情前组4.4%(681/15344),每月45.4例;疫情期间组3.8%(1222/32020),每月37.1例;OR 0.86(95%CI 0.78-0.94,p<0.01)。
  • 中断时间序列分析:ECPR频率每月显著减少17.2例(95%CI -26.0至-8.5,p<0.01);30天良好神经功能预后比例无差异(相对风险1.16,95%CI 0.70-1.96,p=0.56)。

证据类型、等级与局限

  • 证据类型:基于全国登记数据的回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,尽管疫情期间院外心脏骤停患者接受ECPR的频率下降,但包括良好神经功能预后在内的预后未见差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The influence of the COVID-19 pandemic on out-of-hospital cardiac arrest (OHCA) patients who received extracorporeal pulmonary resuscitation (ECPR) has not yet been fully elucidated. We examined whether there were differences in ECPR frequency and outcomes for OHCA patients who received ECPR during the pandemic.

METHODS: Using the nationwide JAAM-OHCA registry, we evaluated OHCA patients who received ECPR from 2019 to 2022. Since the first state of emergency was declared in April 2020, we compared outcomes for OHCA patients before the pandemic (January 1, 2019 to March 31, 2020) and those during the pandemic (from April 1, 2020 to December 31, 2022). We performed logistic regression analysis adjusted for age, sex, witnessed cardiac arrest, bystander cardiopulmonary resuscitation, initial/on hospital arrival shockable rhythm, and time from call to extracorporeal membrane oxygenation initiation, as well as interrupted time series analysis (ITSA). The primary outcome was the proportion of 30-day favorable neurological outcomes, defined as Cerebral Performance Category scores of 1-2 between two groups.

RESULTS: After excluding patients, 1903 ECPR cases (681 in the pre-pandemic group and 1222 in the pandemic group) were included in the study. ECPR frequency decreased during the pandemic (4.4 % [681/15,344], 45.4 cases per month in the pre-pandemic group, and 3.8 % [1222/32,020], 37.1 cases per month in the pandemic group, odds ratio (OR) 0.86, 95 % confidence interval (CI) 0.78-0.94, p < 0.01). Multivariable logistic regression analysis revealed the COVID-19 pandemic was not associated with 30-day favorable neurological outcomes (12.5 % [85/681] in the pre-pandemic group and 12.6 % [154/1221] in the pandemic group, OR 0.92, 95 % CI 0.67-1.30, p = 0.64). ITSA revealed the frequency of ECPR decreased significantly (-17.2 per month, 95 % CI -26.0--8.5, p < 0.01), while the proportion of 30-day favorable neurological outcomes did not differ (relative risk 1.16, 95 % CI 0.70-1.96, p = 0.56) during the pandemic period.

CONCLUSIONS: Although the frequency of ECPR for OHCA patients decreased, prognoses, including favorable neurological outcomes, did not differ during the COVID-19 pandemic.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Nishimura T, Nakatani Y, Kaneda H, et al. Impact of COVID-19 pandemic on out-of-hospital cardiac arrest patients who received extracorporeal pulmonary resuscitation. Am J Emerg Med. 2025. PMID: 40912215. doi:10.1016/j.ajem.2025.08.056

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。